Based on these findings, it appears that prescribing a combination of anti-inflammatory and anti-migraine medications alongside DAO enzyme supplementation for migraine patients who also have DAO deficiency may represent a valuable strategy in the management of migraine and in the prevention of medication-overuse headaches. This evidence concerns the gene DAO and migraine disorder.